XML 34 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements
12 Months Ended
Dec. 31, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measurements
NOTE 13.  FAIR VALUE MEASUREMENTS
ASC Topic 820, “Fair Value Measurement,” defines fair value, establishes a framework for measuring fair value including a three‑level valuation hierarchy, and expands disclosures about fair value measurements. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date reflecting assumptions that a market participant would use when pricing an asset or liability. The hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows:
Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2: Observable inputs other than Level 1, including quoted prices for similar assets and liabilities in active markets, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data, either directly or indirectly, for substantially the full term of the financial instrument. This category generally includes municipal securities, government agency and government‑sponsored enterprise securities, collateralized loan obligations, and registered publicly rated private label collateralized mortgage obligations ("CMOs") and asset-backed securitizations.
Level 3: Inputs to a valuation methodology that are unobservable, supported by little or no market activity, and significant to the fair value measurement. These valuation methodologies generally include pricing models, discounted cash flow models, or a determination of fair value that requires significant management judgment or estimation. This category also includes observable inputs from a pricing service not corroborated by observable market data, and includes our covered private label CMOs, non-rated private placement private label CMOs, non-rated private placement asset-backed securities, and equity warrants.
We use fair value to measure certain assets and liabilities on a recurring basis, primarily securities available‑for‑sale and derivatives. For assets measured at the lower of cost or fair value, the fair value measurement criteria may or may not be met during a reporting period and such measurements are therefore considered “nonrecurring” for purposes of disclosing our fair value measurements. Fair value is used on a nonrecurring basis to adjust carrying values for impaired loans and other real estate owned and also to record impairment on certain assets, such as goodwill, core deposit intangibles, and other long‑lived assets.
The following tables present information on the assets measured and recorded at fair value on a recurring basis as of the dates indicated:
 
Fair Value Measurements as of
 
December 31, 2015
Measured on a Recurring Basis:
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Securities available‑for‑sale:
 
 
 
 
 
 
 
Government agency and government‑sponsored enterprise
 
 
 
 
 
 
 
pass-through securities
$
767,797

 
$

 
$
767,797

 
$

Government agency and government‑sponsored enterprise
 
 
 
 
 
 
 
collateralized mortgage obligations
486,239

 

 
486,239

 

Covered private label collateralized mortgage obligations
29,782

 

 

 
29,782

Other private label collateralized mortgage obligations
115,014

 

 
63,555

 
51,459

Municipal securities
1,547,331

 

 
1,547,331

 

US Treasury securities
69,380

 
69,380

 

 

Corporate debt securities
48,424

 

 
48,424

 

Collateralized loan obligations
132,189

 

 
132,189

 

SBA securities
211,157

 

 
211,157

 

Government‑sponsored enterprise debt securities
36,913

 

 
36,913

 

Asset-backed and other securities
115,211

 
2,562

 
94,449

 
18,200

Total securities available-for-sale
3,559,437

 
71,942

 
3,388,054

 
99,441

Derivative assets
11,919

 

 
11,919

 

Equity warrants
4,914

 

 

 
4,914

Total recurring assets
$
3,576,270

 
$
71,942

 
$
3,399,973

 
$
104,355

Derivative liabilities
$
1,397

 
$

 
$
1,397

 
$


 
Fair Value Measurements as of
 
December 31, 2014
Measured on a Recurring Basis:
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Securities available‑for‑sale:
 
 
 
 
 
 
 
Government agency and government‑sponsored enterprise
 
 
 
 
 
 
 
pass-through securities
$
535,672

 
$

 
$
535,672

 
$

Government agency and government‑sponsored enterprise
 
 
 
 
 
 
 
collateralized mortgage obligations
277,946

 

 
277,946

 

Covered private label collateralized mortgage obligations
33,947

 

 

 
33,947

Other private label collateralized mortgage obligations
10,914

 

 
10,914

 

Municipal securities
536,116

 

 
536,116

 

Corporate debt securities
110,109

 

 
110,109

 

Government‑sponsored enterprise debt securities
36,757

 

 
36,757

 

Asset-backed and other securities
25,716

 
519

 
25,197

 

Total securities available-for-sale
1,567,177

 
519

 
1,532,711

 
33,947

Derivative assets
5,234

 

 
5,234

 

Total recurring assets
$
1,572,411

 
$
519

 
$
1,537,945

 
$
33,947

Derivative liabilities
$
118

 
$

 
$
118

 
$


During the year ended December 31, 2015, $1.4 million of other securities measured at fair value on a recurring basis transferred from Level 2 to Level 1. During the year ended December 31, 2015, we added the following Level 3 assets measured at fair value on a recurring basis from the Square 1 acquisition: non-rated private placement private label CMOs, non-rated private placement asset-backed securities, and equity warrants with fair values of $51.5 million, $18.2 million, and $4.9 million, respectively, at December 31, 2015.
The following table presents information about quantitative inputs and assumptions used to determine the fair values provided by our third party pricing service or broker quotes for our Level 3 private label CMOs (both covered and non-rated private placement) measured at fair value on a recurring basis as of December 31, 2015:
 
Level 3 Private Label CMOs
 
Range of Inputs
 
Weighted Average Input
Unobservable Inputs:
 
 
 
Voluntary annual prepayment speeds
0% - 20.55%
 
8.8%
Annual default rates
0% - 7.10%
 
3.4%
Loss severity rates
0% - 100%
 
44.3%
Discount rates
0% - 43.22%
 
4.4%

The following table presents information about quantitative inputs and assumptions used to determine the fair values provided by our third party pricing service or broker quotes for our Level 3 asset-backed securities measured at fair value on a recurring basis as of December 31, 2015:
 
Level 3 Asset-Backed Securities
 
Range of Inputs
 
Weighted Average Input
Unobservable Inputs:
 
 
 
Voluntary annual prepayment speeds
11.85% - 15%
 
13.4%
Annual default rates
0% - 8.10%
 
4.1%
Loss severity rates
0% - 91%
 
45.5%
Discount rates
2.79% - 4.56%
 
3.7%

The following table presents information about the quantitative inputs and assumptions used in the modified Black-Scholes option pricing model to determine the fair value for our Level 3 equity warrants measured at fair value on a recurring basis as of December 31, 2015:
 
Equity Warrants
 
Weighted Average
 
Range of Inputs
Unobservable Inputs:
 
Volatility
18.8% - 121.9%
Risk-free interest rate
1.0% - 1.5%
Remaining life assumption
19.9% - 49.5%
The following table summarizes activity for our Level 3 private label CMOs measured at fair value on a recurring basis for the years indicated:
 
Year Ended December 31,
Level 3 Private Label CMOs:
2015
 
2014
 
2013
 
(In thousands)
Balance, beginning of year
$
33,947

 
$
37,904

 
$
44,684

Total realized in earnings
1,104

 
1,627

 
1,938

Total unrealized loss in comprehensive income
(1,388
)
 
(344
)
 
(1,204
)
Net settlements
(3,881
)
 
(5,240
)
 
(7,514
)
Addition from the Square 1 acquisition
51,459

 

 

Balance, end of year
$
81,241

 
$
33,947

 
$
37,904


The following table summarizes activity for our Level 3 equity warrants measured at fair value on a recurring basis for the period from acquisition date to December 31, 2015:
 
Period Ended
Equity Warrants:
December 31, 2015
 
(In thousands)
Balance, acquisition date
$
5,552

Total realized in earnings
530

Transfers to securities available-for-sale
(2
)
Sales
(1,529
)
Issuances
363

Balance, end of year
$
4,914


The following tables present assets measured at fair value on a non‑recurring basis as of the dates indicated:
 
Fair Value Measurement as of
 
December 31, 2015
Measured on a Non‑Recurring Basis:
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Impaired Non‑PCI loans
$
40,817

 
$

 
$
9,367

 
$
31,450

Other real estate owned
14,101

 

 
14,101

 

Investments carried at cost
107

 

 

 
107

Total non-recurring
$
55,025

 
$

 
$
23,468

 
$
31,557

 
Fair Value Measurement as of
 
December 31, 2014
Measured on a Non‑Recurring Basis:
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Impaired Non‑PCI loans
$
42,693

 
$

 
$
2,366

 
$
40,327

Other real estate owned
24,015

 

 
18,400

 
5,615

Investments carried at cost
566

 

 

 
566

Total non-recurring
$
67,274

 
$

 
$
20,766

 
$
46,508


The following table presents losses recognized on assets measured on a nonrecurring basis for the years indicated:
 
Year Ended December 31,
Loss on Assets Measured on a Non‑Recurring Basis:
2015
 
2014
 
2013
 
(In thousands)
Impaired Non‑PCI loans
$
(16,097
)
 
$
(7,006
)
 
$
(1,206
)
Other real estate owned
(4,726
)
 
(6,737
)
 
(1,045
)
Investments carried at cost
(17
)
 
(141
)
 

Total net loss
$
(20,840
)
 
$
(13,884
)
 
$
(2,251
)

The following table presents the valuation methodology and unobservable inputs for Level 3 assets measured at fair value on a nonrecurring basis as of December 31, 2015:
Asset
Fair Value
(In thousands)
 
Valuation Technique
 
Unobservable Inputs
 
Range
 
Weighted
Average
Impaired Non-PCI loans
$
30,339

 
Discounted cash flows
 
Discount rates
 
0% - 9.04%
 
5.92%
 
1,111

 
Third party appraisals
 
No discounts
 
 
 
 
Investments carried at cost
107

 
Market and income approach
 
Illiquidity discount
 
75%
 
75%
Total non-recurring Level 3
$
31,557

 
 
 
 
 
 
 
 

ASC Topic 825, “Financial Instruments,” requires disclosure of the estimated fair value of certain financial instruments and the methods and significant assumptions used to estimate such fair values. Additionally, certain financial instruments and all nonfinancial instruments are excluded from the applicable disclosure requirements.
The following tables present a summary of the carrying values and estimated fair values of certain financial instruments as of the dates indicated:
 
December 31, 2015
 
Carrying or
Contract
 
Estimated Fair Value
 
Amount
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
161,020

 
$
161,020

 
$
161,020

 
$

 
$

Interest‑earning deposits in financial institutions
235,466

 
235,466

 
235,466

 

 

Securities available‑for‑sale
3,559,437

 
3,559,437

 
71,942

 
3,388,054

 
99,441

Investment in FHLB stock
19,710

 
19,710

 

 
19,710

 

Investments carried at cost
2,267

 
6,789

 

 

 
6,789

Loans and leases, net
14,363,143

 
14,393,558

 

 
9,367

 
14,384,191

Derivative assets
11,919

 
11,919

 

 
11,919

 

Equity warrants
4,914

 
4,914

 

 

 
4,914

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 
 
 
 
 
 
 
 
 
Deposits:
 
 
 
 
 
 
 
 
 
Demand, interest checking, money market, and savings deposits
11,513,826

 
11,513,826

 

 
11,513,826

 

Time deposits
4,152,356

 
4,152,920

 

 
4,152,920

 

Borrowings
621,914

 
622,438

 
618,000

 
4,438

 

Subordinated debentures
436,000

 
419,762

 

 
419,762

 

Derivative liabilities
1,397

 
1,397

 

 
1,397

 


 
December 31, 2014
 
Carrying or
Contract
 
Estimated Fair Value
 
Amount
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
164,757

 
$
164,757

 
$
164,757

 
$

 
$

Interest‑earning deposits in financial institutions
148,469

 
148,469

 
148,469

 

 

Securities available‑for‑sale
1,567,177

 
1,567,177

 
519

 
1,532,711

 
33,947

Investment in FHLB stock
40,609

 
40,609

 

 
40,609

 

Investments carried at cost
3,691

 
3,691

 

 

 
3,691

Investments accounted for under the equity method
21,461

 
21,700

 

 

 
21,700

Loans and leases, net
11,797,977

 
11,757,951

 

 
2,366

 
11,755,585

Derivative assets
5,234

 
5,234

 

 
5,234

 

Financial Liabilities:
 
 
 
 
 
 
 
 
 
Deposits:
 
 
 
 
 
 
 
 
 
Demand, interest checking, money market, and savings deposits
6,256,190

 
6,256,190

 

 
6,256,190

 

Time deposits
5,498,938

 
5,502,479

 

 
5,502,479

 

Borrowings
383,402

 
383,539

 
380,000

 
3,539

 

Subordinated debentures
433,583

 
417,657

 

 
417,657

 

Derivative liabilities
118

 
118

 

 
118

 


The following is a description of the valuation methodologies used to measure our assets recorded at fair value (under ASC Topic 820, “Fair Value Measurement”) and for estimating fair value for financial instruments not recorded at fair value (under ASC Topic 825).
Cash and due from banks. The carrying amount is assumed to be the fair value because of the liquidity of these instruments.
Interest‑earning deposits in financial institutions. The carrying amount is assumed to be the fair value given the short‑term nature of these deposits.
Securities available‑for‑sale. Securities available‑for‑sale are measured and carried at fair value on a recurring basis. Unrealized gains and losses on available‑for‑sale securities are reported as a component of “Accumulated other comprehensive income” in the consolidated balance sheets. See Note 6. Investment Securities, for further information on unrealized gains and losses on securities available‑for‑sale.
Fair value for securities categorized as Level 1, which are publicly traded securities, are based on readily available quoted prices. In determining the fair value of the securities categorized as Level 2, we obtain a report from a nationally recognized broker‑dealer detailing the fair value of each investment security we hold as of each reporting date. The broker‑dealer uses observable market information to value our securities, with the primary source being a nationally recognized pricing service. We review the market prices provided by the broker‑dealer for our securities for reasonableness based on our understanding of the marketplace and we consider any credit issues related to the securities. As we have not made any adjustments to the market quotes provided to us and they are based on observable market data, they have been categorized as Level 2 within the fair value hierarchy.
Our covered private label CMOs, non-rated private placement private label CMOs, and non-rated private placement asset-backed securities (collectively, “the Level 3 Securities”) were categorized as Level 3 due in part to the inactive market for such securities. There is a wide range of prices quoted for our Level 3 Securities among independent third party pricing services, and this range reflects the significant judgment being exercised over the assumptions and variables that determine the pricing of such securities. We consider this subjectivity relating to our Level 3 Securities to be a significant unobservable input. Our fair value estimate was based on either 1) prices provided to us by a nationally recognized pricing service which we also use to determine the fair value of the majority of our securities portfolio, or 2) pricing estimates we obtained from brokers. We determined the reasonableness of the fair values by reviewing assumptions at the individual security level about prepayment, default expectations, estimated loss severity factors, and discount rates, all of which are not directly observable in the market. Significant changes in default expectations, loss severity factors, or discount rates, which occur all together or in isolation, would result in different fair value measurements.
FHLB stock. Investments in FHLB stock are recorded at cost and measured for impairment quarterly. Ownership of FHLB stock is restricted to member banks and the securities do not have a readily determinable market value. Purchases and sales of these securities are at par value with the issuer. The fair value of investments in FHLB stock is equal to the carrying amount.
Non-PCI loans and leases. As Non-PCI loans and leases are not measured at fair value, the following discussion relates to estimating the fair value disclosures under ASC Topic 825. Fair values are estimated for portfolios of loans and leases with similar financial characteristics. Loans are segregated by type and further segmented into fixed and adjustable rate interest terms by credit risk categories. The fair value estimates do not take into consideration the value of the loan portfolio in the event the loans are sold outside the parameters of normal operating activities. The fair value of performing fixed-rate loans is estimating by discounting scheduled cash flows through the estimated maturity using estimated market prepayment speeds. The fair value of equipment leases is estimated by discounting scheduled lease and expected lease residual cash flows over their remaining term. The estimated market discount rates used for performing fixed-rate loans and equipment leases are current market rates for instruments with similar risk and similar terms. The fair value of performing adjustable-rate loans is estimated by discounting scheduled cash flows through the next repricing date. As these loans reprice frequently at market rates and the credit risk is not considered to be greater than normal, the market value is typically close to the carrying amount of these loans. These methods and assumptions are not based on the exit price concept of fair value.
Impaired Non‑PCI loans. Nonaccrual loans and performing restructured loans are considered impaired for reporting purposes and are measured and recorded at fair value on a non‑recurring basis. Nonaccrual Non‑PCI loans with an unpaid principal balance over $250,000 and all performing restructured loans are reviewed individually for the amount of impairment, if any. Nonaccrual Non‑PCI loans with an unpaid principal balance less than $250,000 are not individually assessed for impairment but are instead reserved for under our general reserve component.
To the extent a loan is collateral dependent, we measure such impaired loan based on the estimated fair value of the underlying collateral. The fair value of each loan’s collateral is generally based on estimated market prices from an independently prepared appraisal, which is then adjusted for the cost related to liquidating such collateral; such valuation inputs result in a nonrecurring fair value measurement that is categorized as a Level 2 measurement. The Level 2 measurement is based on appraisals obtained within the last 12 months and for which a charge‑off was recognized or a change in the specific valuation allowance was made during the year ended December 31, 2015.
When adjustments are made to an appraised value to reflect various factors such as the age of the appraisal or known changes in the market or the collateral, such valuation inputs are considered unobservable and the fair value measurement is categorized as a Level 3 measurement. The impaired loans categorized as Level 3 also include unsecured loans and other secured loans whose fair values are based significantly on unobservable inputs such as the strength of a guarantor, including an SBA government guarantee, cash flows discounted at the effective loan rate, and management’s judgment.
The impaired Non‑PCI loan balances shown above as measured on a non-recurring basis represent those nonaccrual and restructured loans for which impairment was recognized during the year ended December 31, 2015. The amounts shown as net losses include the impairment recognized during the year ended December 31, 2015, for the loan balances shown. Of the $129.0 million of nonaccrual Non-PCI loans at December 31, 2015, $20.0 million were written down to their collateral fair values through charge‑offs during the year ended December 31, 2015.
Investments that do not have readily determinable fair values. Other investments accounted for under the cost or equity methods of accounting are carried at fair value on a nonrecurring basis to the extent that they are determined to be other-than-temporarily impaired during the period. As there is rarely an observable price or market for such investments, we determine fair value using internally developed models. Our models utilize industry valuation benchmarks, such as multiples of net revenue or EBITDA, to determine a value for the underlying enterprise. We may also reduce the value determined by the model due to illiquidity or other investee-specific characteristics which may affect the fair value. Significant decreases to these valuation benchmarks would result in significant decreases in the estimated fair values. We reduce this value by the value of debt outstanding to arrive at an estimated equity value of the enterprise. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the pricing indicated by the external event is used to corroborate our internal valuation. Fair value measurements related to these investments are typically classified within Level 3 of the fair value hierarchy.
Other real estate owned ("OREO"). The fair value of foreclosed real estate is generally based on the lower of estimated market prices from independently prepared current appraisals or negotiated sales prices with potential buyers, less estimated costs to sell; such valuation inputs result in a fair value measurement that is categorized as a Level 2 measurement on a nonrecurring basis. As a matter of policy, appraisals are required annually and may be updated more frequently as circumstances require in the opinion of management. The Level 2 measurement for OREO is based on appraisals obtained within the last 12 months and for which a write‑down was recognized during the year ended December 31, 2015.
When a current appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value as a result of known changes in the market or the collateral and there is no observable market price, such valuation inputs result in a fair value measurement that is categorized as a Level 3 measurement. To the extent a negotiated sales price or reduced listing price represents a significant discount to an observable market price, such valuation input would result in a fair value measurement that is also considered a Level 3 measurement. The OREO losses disclosed are write‑downs based on either a recent appraisal obtained after foreclosure or an accepted purchase offer by an independent third party received after foreclosure.
Deposits. Deposits are carried at historical cost. The fair value of deposits with no stated maturity, such as noninterest‑bearing demand deposits, interest checking, money market, and savings accounts, is equal to the amount payable on demand as of the balance sheet date and considered Level 2. The fair value of time deposits is based on the discounted value of contractual cash flows and considered Level 2. The discount rate is estimated using the rates currently offered for deposits of similar remaining maturities. No value has been separately assigned to the Company’s long‑term relationships with its deposit customers, such as a core deposit intangible.
Borrowings. Borrowings include overnight FHLB advances and other fixed‑rate term borrowings. Borrowings are carried at amortized cost. The fair value of overnight FHLB advances is equal to the carrying value and considered Level 1. The fair value of fixed‑rate borrowings is calculated by discounting scheduled cash flows through the estimated maturity dates or call dates, if applicable, using estimated market discount rates that reflect current rates offered for borrowings with similar remaining maturities and characteristics and are considered Level 2.
Subordinated debentures. Subordinated debentures are carried at amortized cost. The fair value of subordinated debentures with variable rates is determined using a market discount rate on the expected cash flows.
Derivative assets and liabilities. Derivatives are carried at fair value on a recurring basis and primarily relate to forward exchange contracts which we enter into to manage foreign exchange risk. Our derivatives are principally traded in over-the-counter markets where quoted market prices are not readily available. Instead, the fair value of derivatives is estimated using market observable inputs such as foreign exchange forward rates, interest rate yield curves, volatilities and basis spreads. We also consider counterparty credit risk in valuing our derivatives. We typically classify our foreign exchange derivatives in Level 2 of the fair value hierarchy.
Warrants. Equity warrants with net settlement terms are received in connection with extending loan commitments to certain of our customers. We estimate the fair value of equity warrants using a Black-Scholes option pricing model to approximate fair market value. For warrants of private companies, the model estimates market value for each warrant based on the most recent equity offering at the time of issuance, the warrant's exercise price, the warrant's expected life, a risk-free interest rate based on a duration-matched U.S. Treasury rate and volatility factors derived from the iShares Russell Microcap index (IWC). For warrants of publicly-traded companies, the model estimates market value for each warrant based on the share price as of the evaluation date, the warrant's exercise price, the warrant's expected life, a risk-free interest rate based on a duration-matched U.S. Treasury rate and uses a company-specific volatility factor. We typically classify our equity warrant derivatives in Level 3 of the fair value hierarchy.
Commitments to extend credit. The majority of our commitments to extend credit carry current market interest rates if converted to loans. Because these commitments are generally not assignable by either the borrower or us, they only have value to the borrower and us. The estimated fair value approximates the recorded deferred fee amounts and is excluded from the table above because it is not material.
Limitations
Fair value estimates are made at a specific point in time and are based on relevant market information and information about the financial instrument. These estimates do not reflect income taxes or any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Because no market exists for a portion of the Company’s financial instruments, fair value estimates are based on what management believes to be conservative judgments regarding expected future cash flows, current economic conditions, risk characteristics of various financial instruments, and other factors. These estimated fair values are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Since the fair values have been estimated as of December 31, 2015, the amounts that will actually be realized or paid at settlement or maturity of the instruments could be significantly different.